Rheumatology

INTRODUCTION

Fibromyalgia is a disease characterized by chronic diffuse musculoskeletal pain. The symptoms of the disease are fatigue, sleep disorder, anxiety or depression as well as gastrointestinal symptoms, such as irritable bowel or diffuse abdominal pains.  Pain that lasts more than three months is considered chronic, and pain that is located in both hemispheres of the body, is considered diffuse. Women are more likely to develop fibromyalgia than men. The therapeutic options are mainly antidepressants but also drugs for neuropathic pain, while the main goal for these patients is to reduce pain and improve sleep quality.

PRODUCT INFORMATION

Reumaspis is a special nutritional formulation with ingredients that help to manage the symptoms of fibromyalgia, reducing pain and sensitivity. Reumaspis contains specially produced red ginseng, which offers anti-inflammatory and antioxidant action.

The antioxidant action of red ginseng is enhanced by astaxanthin, providing the necessary antioxidant mechanism to nerve cells. Astaxanthin, which is included in the product, is literally hundreds of times stronger than other antioxidant molecules. Astaxanthin comes from the algae of the genus Haematococcus pluvialis and is a natural carotenoid.

Reumaspis includes ingredients with a positive effect on the patient's mood. The main ingredient with the above action is the stigma of Crocus sativus L, which is a plant with a long history and use. Lastly, Reumaspis contains magnesium*, vitamin D3* and B12, ingredients that contribute to the normal function of bones.

*Health claims according to (EU) Regulation  432/2012: Vitamin D and magnesium to the maintenance of normal bones

INTRODUCTION

Osteoarthritis or known as chronic joint degeneration, is the most common form of Arthritis. Osteoarthritis can cause cartilage degeneration and affects mainly people of advanced age. It can affect any joint of the human body, but mostly affects the joints that are strained on a daily basis (e.g., knee, hand, spine). Τhe disease shows gradually progression and according to the severity of the symptoms, is classified from stage I to stage IV (stage IV more severe). The late stages are the most severe where the symptoms are intense and daily life is becoming more and more difficult. The most common symptoms are pain, stiffness and tenderness. Existing treatment options focus on relief of pain such as injections of hyaluronic acid.

PRODUCT INFORMATION

Arthroaspis Motus is a nutritional formulation with ingredients that help to manage stage 3 & 4 osteoarthritis. Its ingredients help to reduce pain and stiffness, as well as to slow the progression of the disease. They act as a joint lubricant, relieving joint pain.

The product includes high molecular weight hyaluronic acid to ensure its absorption and availability, which is an important component of cartilage and joint lubrication.  Arthroaspis Motus contains ingredients with high antioxidant activity providing patients with a benefit in movement.

The eggshell membrane component included in Arthroaspis Motus is clinically proven to benefit osteoarthritis patients. In addition, Arthroaspis Motus contains selenium, which has a protective role in cartilage. Finally, it includes vitamin D3, which covers the needs of patients with osteoarthritis and at the same time contributes to the maintenance of normal bones.

*Health claims according to (EU) Regulation  432/2012: Vitamin D contributes to the maintenance of normal bones

INTRODUCTION

Sjögren Syndrome is an autoimmune disease that affects the whole body. Its name comes from the Swedish ophthalmologist Henrik Sjögren who was the first to identify the disease. In Sjögren Syndrome the immune system mainly attacks the lacrimal and salivary glands, causing dry mouth and/or dry eyes. The syndrome mainly affects women aged 40–60. In addition to dry eyes, patients with Sjogren's disease also experience meibomianitis. What dry eye has in common with meibomianitis is the disturbance of the balance in the tear film which is characterized by inflammation and eye symptoms. Existing treatment options focus on topical relief by lubricating the cornea.

PRODUCT INFORMATION

Eyeaspis DE-Caps is a formulation, with ingredients that help to manage dry eyes and decongest the meibomian gland. Eyeaspis DE-Caps contains ingredients with proven anti-inflammatory action, as well as the substance of fatty acid in the meibomian gland to produce the right quality and quantity of the lipid layer (meibum).

Key components of the lipid layer with a strong anti-inflammatory effect are ω-3 fatty acids such as eicosapentaenoic acid (EPA), which is an essential fatty acid for the functions of the body and which the body is unable to synthesize on its own.

Eyeaspis DE-Caps has as its main ingredient EPA in form of re-esterified triglycerides and with anti-inflammatory action, as well as maqui berry extract, with antioxidant action (35% delphinidins). In addition, vitamin D3 and vitamin B12 both of which cover the basic needs of the body.

INTRODUCTION

Sjögren Syndrome is an autoimmune disease that affects the whole body. Its name comes from the Swedish ophthalmologist Henrik Sjögren who was the first to identify the disease. In Sjögren Syndrome the immune system mainly attacks the lacrimal and salivary glands, causing dry mouth and/or dry eyes. The syndrome mainly affects women aged 40–60. In addition to dry eyes, patients with Sjogren's disease also experience meibomianitis. What dry eye has in common with meibomianitis is the disturbance of the balance in the tear film which is characterized by inflammation and eye symptoms. Existing treatment options focus on topical relief by lubricating the cornea.

PRODUCT INFORMATION

Eyeaspis Dry Eye is a formulation, with ingredients that help to manage dry eyes and decongest the meibomian gland. Eyeaspis DE-Caps contains ingredients with proven anti-inflammatory action, as well as the substance of fatty acid in the meibomian gland to produce the right quality and quantity of the lipid layer (meibum).

Key components of the lipid layer with a strong anti-inflammatory effect are ω-3 fatty acids such as eicosapentaenoic acid (EPA), which is an essential fatty acid for the functions of the body and which the body is unable to synthesize on its own.

Eyeaspis Dry Eye has as its main ingredients EPA and DHA in re-esterified form of triglycerides and with anti-inflammatory action. In addition, vitamin D3 with 1000IU covers the basic needs of the body.

*Health claims according to (EU) Regulation 432/2012: DHA contributes to the maintenance of normal vision.